Home

Takeda Pharmaceuticals International AG

CIK 1688140 · last filed 2017-04-19

Takeda Pharmaceuticals International AG is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing, for MYOV, was dated Apr 19, 2017. The firm reports its address in Zurich, V8. 4 SEC filings were submitted jointly with TAKEDA PHARMACEUTICAL CO LTD.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
THURGAUERSTRASSE 130
GLATTPARK-OPFIKON
ZURICH, V8 8152
Phone
41-44-555-10-00
State of Incorporation
Switzerland
Related Filers
TAKEDA PHARMACEUTICAL CO LTD — 4 joint filings, latest 2019-05-13
Takeda Pharmaceuticals U.S.A., Inc. — 3 joint filings, latest 2019-05-13
Takeda Europe Holdings B.V. — 2 joint filings, latest 2018-03-21
Takeda Ventures, Inc. — 2 joint filings, latest 2019-05-13
MILLENNIUM PHARMACEUTICALS INC — 1 joint filings, latest 2017-09-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Myovant Sciences Ltd. (MYOV) Delisted 10%+ Owner 7,420,625 $26.98 $200.21M $0 4 2017-04-19

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-04-19 Myovant Sciences Ltd. (MYOV) Delisted Exer (M) +4,432 $0 EDGAR
2017-03-24 Myovant Sciences Ltd. (MYOV) Delisted Exer (M) +19,936 $0 EDGAR
2017-03-13 Myovant Sciences Ltd. (MYOV) Delisted Exer (M) +27,868 $0 EDGAR
2016-11-03 Myovant Sciences Ltd. (MYOV) Delisted Exer (M) +1,977,269 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.